The Challenge of getting things done

•

7 gostaram•1,568 visualizações

Deep Bhandari

Mais conteúdo relacionado

Destaque

Redox flow battery - Power Sector

Irish Pereira

OTC Drugs - Sales Model

Shubhankar Mazumdar

2016 IMS Asia-Pacific Insight Magazine

QuintilesIMS Asia Pacific

OTC Drug Market - Future Growth Driver for IPM

Shubhankar Mazumdar

At comScore, we’ve planned a year’s worth of work for an organization of 140+ members across multiple teams, with several business units all collaborating on various projects. And like many, we’re an organization trying to stay agile along the way. Learn about our successes and lessons that got us to this point, and how implementing Portfolio for JIRA has changed the way we plan. We’ll go into how we do Capacity Planning, People Management, Schedule Management, and Reporting, with insight from both a PM and Engineering Manager. Find out how teams can leverage Portfolio to strategically plan and quickly adapt to a changing landscape, and track progress on their projects. Products covered: Portfolio for JIRA

Wonders of Portfolio = Long Term Planning + Agility

Atlassian

Indian healthcare industry 2016

Irish Pereira

By Mr. Irish Pereira. The report present snapshot of Indian Pharmaceutical industry in both domestic as well as export market. It is collation of facts pertaining to Indian pharma exports and explore key emerging trends pertaining to pharma export market. It describes key players of Indian pharma market and their export orientation as in their target export destinations, their focus therapies etc. Fact sheet: 1) Indian Pharma Market size 2015 2) Indian pharmaceutical market segments by value 3)Patented (Innovator) Vs Generics Scenario 4)Growth drivers of Indian pharmaceutical industry 5) Indian Pharmaceutical sector – SWOT Analysis 6)PHARMEXCIL – Facilitating agency for Indian Pharma Exports 7) Indian Pharmaceutical Exports (USD bn) 8)Formulations share in Total Pharma Exports (2014-15) 9) Top 25 destination countries of India’s pharmaceutical exports during 2013-14 (INR mn) 10) Major Indian Pharma Companies (By Revenue-USD mn) 11) Pharma players and their export destinations Sun Pharma,Dr. Reddy’s Lab, CIPLA, Lupin, Aurobindo, Cadila Healthcare, Torrent Pharma, Wockhardt, 12) Emerging trends in Indian Pharma Market

Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...

Irish Pereira

Turn customer needs into business opportunities

Dr. Marc Sniukas

Demonetization - Impact on Indian Pharma

Anup Soans

Guest Editorial - Gender Gap in Indian Pharma - An Unaddressed Issue .............................................................................. Inside this Issue 1. A Salesforce Retention Strategy for Indian Pharma by K. Hariram A quantitative and qualitative approach to measuring and stemming the tide of attrition in pharma sales. 2. “I Am Waiting for the Day When Pharma Hires a CEO from a Tech Company” an Interview with Salil Kallianpur Salil Kallianpur – Executive Vice President – Primary Care at GSK shares his thoughts on Indian pharma in 2017 and beyond with MedicinMan. 3. 1st World Pharma Brand Managers Day by Prof. Suniel Deshpande and Vivek Hattangadi A report on the 1st World Pharma Brand Managers Day which began with a Pharma CEO Conclave. 4. Pharma L&D Beyond the Classroom by Diksha Fouzdar Real learning almost always takes place outside the classroom, but internalizing that in L&D requires a mindset change.

Why are there only 15% to 20% Women in Indian Pharma?

Anup Soans

The Government of India’s well-intentioned move to de-monetize currency notes of INR 500 and INR 1000, has been expected to cause near-term business disruptions across sectors. Within pharmaceuticals, this has implications for different stakeholders, ranging from pharmaceutical companies to distribution channel, patients & physicians. In an attempt to understand the effect of the announcement on the drug distribution network, QuintilesIMS conducted a survey across roughly 500+ chemists around the country. The objective was to understand short-term as well as potentially lingering effects of the demonetization move. Key points of investigation ranged from the immediate impact on individual chemist sales & patient footfall to value chain-related aspects such as credit cycles, supply levels, inventory stock levels, etc. as well as measures taken by retailers to manage the effect of the demonetization announcement. This document captures the essence of the study results

Retail Sales of Drugs - Impact of Demonetization

Anup Soans

SAP Production Planning

Rupesh Brahmankar

Destaque (12)

Redox flow battery - Power Sector

OTC Drugs - Sales Model

2016 IMS Asia-Pacific Insight Magazine

OTC Drug Market - Future Growth Driver for IPM

Wonders of Portfolio = Long Term Planning + Agility

Indian healthcare industry 2016

Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...

Turn customer needs into business opportunities

Demonetization - Impact on Indian Pharma

Why are there only 15% to 20% Women in Indian Pharma?

Retail Sales of Drugs - Impact of Demonetization

SAP Production Planning